DIGESTIVE DISEASES AND SCIENCES, cilt.63, sa.5, ss.1348-1354, 2018 (SCI-Expanded)
We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and azathioprine).